
GLOW Blend (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg)
- Per vial
- 70 mg
- Per box
- 10 vials
Code BBG70 / GLOW70

Catalog illustration. Actual packaging and lot details are confirmed on inquiry.
FOXO4-DRI 2 mg is listed at 2 mg per vial, 10 vials per box, under product code F402. It is the smallest of 2 FOXO4-DRI presentations in the catalog, which range from 2 mg to 10 mg per vial. FOXO4-DRI is a cell-penetrating D-retro-inverso peptide that interferes with FOXO4–p53 binding, studied as a senolytic tool in cell and mouse models.
Each option opens its own specification. Availability is confirmed on inquiry.
Let’s put your request together.
Ask for this material’s price, or use + to include it in a combined inquiry.
Presentation: 2 mg per vial, 10 vials/box
No payment is taken here. Confirm specifications, quantities and shipping with our team on WhatsApp.
| Product code | F402 |
|---|---|
| Supplier presentation | 2 mg per vial, 10 vials/box |
| Intended use | Laboratory research only |
Catalog fields are general product information. Confirm the actual label, current lot specification and available documents before relying on a value for procurement or research planning.
Research Use Only. This product is intended strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.
In senescent cells, the transcription factor FOXO4 binds p53 and holds it in the nucleus, which helps those cells avoid apoptosis. FOXO4-DRI is a peptide designed to compete with that interaction. It is built from D-amino acids in reversed sequence order, the D-retro-inverso strategy, which mimics the side-chain layout of the natural sequence while resisting proteases.
Check these points with our team before you order:

Code BBG70 / GLOW70


